As Ebola outbreak grows, the U.S. retreats from the global health leadership. Any Americans who contract Ebola will not be brought to the United States for treatment, Trump admini ...

Ed’s stories explore prescription drug pricing, affordability and access, as well issues surrounding patents, litigation and legislation. He is also the author of the morning Pharmalittle newsletter ...

Sarah covers how industries like food and tobacco affect Americans’ bodies and minds. Her interests include ultra-processed foods; smoke-free tobacco; and wellness trends like perimenopause products ...

This week on "The Readout LOUD," longtime biotech exec Jeremy Levin talks about his new book and the industry's strategic turning point. Listen now.

Mario covers technology in health care, including FDA regulation of artificial intelligence; how Medicare pays for health tech; the use of AI in clinical care; mental health chatbots; and consumer ...

But some patients and their families, worried by misinformation around Covid-19 vaccines, are insisting on getting blood ...

Inside the longevity conference that brings together founders, investors, biohackers, and the generally death-averse to ...

Andrew covers the biopharma industry, scientific research, and public health across the continent. You can reach Andrew confidentially on Signal at drewqjoseph.71. An experimental medicine helped ...

Biotech is producing scientific breakthroughs that once seemed impossible. But according to longtime industry executive Jeremy Levin, the institutions ...

In this morning's Pharmalittle roundup, we're reading about a hepatitis B drug, CVS returns Lilly obesity drug to formularies ...

For Wall Street, the political risk of investing in drug companies has been demoted in comparison to other concerns ...